Management of women with polycystic ovary syndrome who experienced premature luteinization during clomiphene citrate treatment

Objective: To determine the preferred treatment modality in patients with P COS who experienced premature luteinization during CC treatment. Design: Prospective randomized study. Setting: Tertiary medical center. Patients: Twenty-two infertile women with PCOS demonstrating premature lute inization during at least two consecutive CC cycles. Interventions: Randomized induction of ovulation either with FSH alone or w ith GnRH agonist combined with FSH for a single treatment cycle. Main Outcome Measures: Premature luteinization was defined as serum progest erone >1.5 ng/mL before hCG administration. Results: Premature luteinization occurred in eight of the 10 patients (80%) in group A and in two of the 12 patients in group B (16.6%). This result c orresponds to the higher mean (+/-SD) progesterone level present in group A patients as compared to those in group B (2.0 +/- 1.2 ng/mL vs. 1.2 +/- 0. 6 ng/mL, P=0.03). No pregnancies were achieved in group A, whereas the preg nancy rate per cycle observed in group B was 33.3% (4/12). On the day of hC G administration, the maximum mean (+/-SD) estradiol level was significantl y lower (P<0.0001) in group A (210.6 +/- 37.9 pg/mL) than in group B (600.3 +/- 253.8 pg/mL). The treatment duration and the number of FSH ampules use d did not differ between the groups. Conclusions: Pituitary desensitization with GnRH analog in combination with FSH is superior to FSH-only treatment in PCOS patients who demonstrate pre mature luteinization during CC treatment. (Fertil Steril (R) 2000;74:749-52 . (C) 2000 by American Society for Reproductive Medicine.).